A Framework for Clinical Cancer Subtyping from Nucleosome Profiling of Cell-Free DNA
Science in Seattle,
Cell-free DNA (cfDNA) has the potential to inform tumor subtype classification and help guide clinical precision oncology. Here…
Cell-free DNA (cfDNA) has the potential to inform tumor subtype classification and help guide clinical precision oncology. Here…
The paper by Maley et al, NRC 207, highlights the limited practical relevance of a purely intellectual exercise.
Do you want to know more about the story behind some of today’s big developments in sequencing technology? Illumina recently…
In my last post (4/10/14 issue) I reviewed recent advances in non-cancer genomics, particularly the fun stuff involving…